Information on EC 1.14.13.67 - quinine 3-monooxygenase

Word Map on EC 1.14.13.67
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Specify your search results
Select one or more organisms in this record:
Show additional data
Do not include text mining results
Include (text mining) results (more...)
Include results (AMENDA + additional results, but less precise; more...)
Please login to have access to the AMENDA and FRENDA data

The enzyme appears in viruses and cellular organisms

top print hide
EC NUMBER
COMMENTARY hide
1.14.13.67
-
top print hide
RECOMMENDED NAME
GeneOntology No.
quinine 3-monooxygenase
top print hide
REACTION
REACTION DIAGRAM
COMMENTARY hide
ORGANISM
UNIPROT
LITERATURE
quinine + NADPH + H+ + O2 = 3-hydroxyquinine + NADP+ + H2O
show the reaction diagram
-
-
-
-
top print hide
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
oxidation
-
-
-
-
redox reaction
-
-
-
-
reduction
-
-
-
-
top print hide
SYSTEMATIC NAME
IUBMB Comments
quinine,NADPH:oxygen oxidoreductase
-
top
top print hide
CAS REGISTRY NUMBER
COMMENTARY hide
205394-96-3
-
top print hide
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
mouse
-
-
Manually annotated by BRENDA team
rat
-
-
Manually annotated by BRENDA team
top print hide
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
physiological function
-
differences in the activity of both CYP3A4 and CYP3A5 in Koreans, Swedes and Tanzanians. Both 4beta-hydroxycholesterol and quinine/3-hydroxyquinine metabolic ratio show a higher CYP3A activity in women than in men
top print hide
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
etoposide + NADPH + O2
3'-demethyletoposide + NADP+ + H2O
show the reaction diagram
quinine + NADPH + H+ + O2
3-hydroxyquinine + NADP+ + H2O
show the reaction diagram
quinine + NADPH + O2
3-hydroxyquinine + NADP+ + H2O
show the reaction diagram
teniposide + NADPH + O2
teniposide catechol + NADP+ + H2O
show the reaction diagram
-
-
-
?
top print hide
NATURAL SUBSTRATES
NATURAL PRODUCTS
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
quinine + NADPH + H+ + O2
3-hydroxyquinine + NADP+ + H2O
show the reaction diagram
-
-
-
-
?
quinine + NADPH + O2
3-hydroxyquinine + NADP+ + H2O
show the reaction diagram
-
quinine is used for treatment of severe forms of Plasmodium falciparum malaria, phenotyping of two different populations, overview
-
-
?
top print hide
COFACTOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
top print hide
INHIBITORS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
alpha-naphthoflavone
anti-CYP2C antibodies
-
inhibition of 20%
-
anti-CYP3A4 antibodies
-
Chloroquin
diazepam
doxycyclin
etoposide
-
maximum inhibition of quinine 3-hydroxylation of 60% at 0.1 mM
grape seed extract
-
inhibition ranges from 6.4% to 26.8% dependent on the product
-
green tea extract
-
most pronounced inhibition of CYP3A4, which ranges from 5.6% to 89.9% dependent on the product
-
ketoconazole
ketoconazole 2R,4R enantiomer
-
-
ketoconazole 2R,4S enantiomer
-
-
ketoconazole 2S,4R enantiomer
-
-
ketoconazole 2S,4S enantiomer
-
-
p-nitrophenol
primaquine
Quinine
-
maximum inhibition of etoposide 3'-demethylation of 52% at 0.1 mM
S-mephenytoin
sulfaphenazole
-
inhibits more than 50% at 0.1 mM
tetracyclin
troleandomycin
additional information
-
ginseng products have little to no effect on the activity of CYP3A4
-
top print hide
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
alpha-naphthoflavone
diazepam
grape seed extract
-
some brands cause minor activation of CYP3A4
-
top print hide
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.0227 - 0.138
Quinine
additional information
etoposide
top print hide
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.00327 - 0.125
Quinine
top print hide
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.023
ketoconazole 2R,4R enantiomer
Homo sapiens
-
pH 7.4, 37°C
0.014
ketoconazole 2R,4S enantiomer
Homo sapiens
-
pH 7.4, 37°C
0.011
ketoconazole 2S,4R enantiomer
Homo sapiens
-
pH 7.4, 37°C
0.004
ketoconazole 2S,4S enantiomer
Homo sapiens
-
pH 7.4, 37°C
0.01
ketoconazole racemate
Homo sapiens
-
pH 7.4, 37°C
top print hide
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
7.4
-
assay at
top print hide
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
37
-
assay at
top print hide
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
top print hide
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
top print hide
Purification/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
native enzyme partially by microsome preparation
-
top print hide
Cloned/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
expression of CYP3A4 in human B lymphoblastoid cell line AHH-1
-
genes CYP3A5 and CYP3A4, DNA sequence determination, genotyping of two different human populations revealing the CYP3A5 and the CYP3A4 genotypes
-
top print hide
ENGINEERING
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
A6986AG
-
single nucleotide polymorphism responsible for different CYP3A genotypes, CYP3A5 allele and genotype frequency in the populations, overview
additional information
-
the CYP3A5 genotype has significant effect on quinine 3-hydroxylation in black Tanzanians, who have lower total CYP3A activity compared to a population of Swedish caucasians, overview
top print hide
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
medicine
top
top
top
top
LINKS TO OTHER DATABASES (specific for EC-Number 1.14.13.67)
ExplorEnz
ExPASy
KEGG
MetaCyc
SABIO-RK
NCBI: PubMed, Protein, Nucleotide, Structure, Genome, OMIM
IUBMB Enzyme Nomenclature
PROSITE Database of protein families and domains
SYSTERS
Protein Mutant Database
InterPro (database of protein families, domains and functional sites)